ArticleJournal of thoracic disease2025
Incidence and risk factors of posttransplant diabetes mellitus in lung transplant recipients: a retrospective cohort study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-transplantation diabetes mellitus (PTDM) is a common complication after lung transplantation. Its incidence and risk factors are not well defined, and clarifying them is important for guiding prevention and improving patient outcomes. This study aimed to investigate the incidence of PTDM in lung transplant recipients, while also identifying its associated risk factors. The objective is to provide new insights that could inform clinical interventions and strategies for risk reduction. Methods: Data were collected from 158 patients who underwent lung transplantation at a tertiary hospital in Guangzhou, China, between February 2023 and August 2024. The risk factors for PTDM were analyzed using both univariate and multivariate logistic regression models. Results: During the follow-up period, 36.08% (57/158) of patients developed PTDM. Multivariate logistic regression analysis identified several factors that appeared to be independently associated with PTDM after lung transplantation, including cardiac insufficiency [odds ratio (OR) =2.491; P=0.04], hyperlipidemia (OR =7.699; P=0.02), age >45 years (OR =3.822; P=0.02), geriatric nutritional risk index (GNRI) ≤92 (OR =2.529; P=0.02), and hemoglobin A1c (HbA1c) >5.7% (OR =2.414; P=0.02). Conclusions: Preoperative cardiac insufficiency, dyslipidemia, elevated HbA1c, advanced age, and a low GNRI may be associated with an increased risk of PTDM following lung transplantation. These findings underscore the potential importance of comprehensive metabolic assessment and multidisciplinary management; however, prospective studies are needed to confirm these associations and guide preventive strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.